Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

著者: Paolo A. Ascierto, Michele Del Vecchio, Caroline Robert, Andrzej Maćkiewicz, Vanna Chiarion‐Sileni, Ana Arance, Célèste Lebbé, Lars Bastholt, Omid Hamid, Piotr Rutkowski, Catriona M. McNeil, Claus Garbe, Carmen Loquai, Brigitte Dréno, L. Thomas, Jean-Jacques Grob, Gabriella Liszkay, Marta Nyakas, Ralf Gutzmer, Joanna Pikiel, Florent Grange, Christoph Höeller, Virginia Ferraresi, Michael Smylie, Dirk Schadendorf, Laurent Mortier, Inge Marie Svane, Delphine Hennicken, Anila Qureshi, Michele Maio - The Lancet 2017 被引用: 495